Zia Choudhry Launchs a New Digital Education Platform Designed to Inform and Empower People Living With wAIHA
Zia Choudhry, Senior Medical Director Rare Autoantibody Diseases – Immunology at Johnson & Johnson Innovative Medicine, shared a post on LinkedIn:
“At Johnson & Johnson Innovative Medicine, we’re committed to ensuring every patient’s voice is heard and their needs are prioritized. That’s why I’m excited to share the launch of MywAIHAHome.com — a new digital education platform designed to inform and empower people living with warm autoimmune hemolytic anemia (wAIHA) and their care partners.
Because we believe meaningful engagement with the patient community is key to advancing healthcare, in collaboration with patient advocates and healthcare professionals we conducted qualitative research to better understand the needs and preferences of individuals living with wAIHA. Our goal? To develop educational resources that are truly impactful, accessible, and tailored to the patient journey.
At this week’s National Organization for Rare Disorders Breakthrough Summit, I’m proud to be presenting the findings of our research, which highlighted the importance of reliable, easy-to-understand information, support networks, and patient testimonials. Let’s connect if you’re at this week’s meeting in Washington, D.C., or please be sure to visit MywAIHAHome.com today to see what we can achieve when we put patients first.”
Stay informed with Hemostasis Today.
-
May 6, 2026, 12:12Mona Ranade: Insights from a Medeloop Analytics Study Evaluate Catheter-Directed Therapy in Pulmonary Embolism
-
May 6, 2026, 11:50Natalie L. Baggio: A 24/7 Neurointerventional Stroke Care at Corewell Health Is Now a Reality
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?